The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 02, 2022

Filed:

Oct. 04, 2017
Applicant:

Pds Biotechnology Corporation, North Brunswick, NJ (US);

Inventors:

Frank Bedu-Addo, Stamford, CT (US);

Greg Conn, Madrid, ES;

Martin Ward, Lexington, KY (US);

Jerold Woodward, Lexington, KY (US);

Assignee:

PDS Biotechnology Corporation, North Brunswick, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/025 (2006.01); C07K 14/01 (2006.01); A61K 9/127 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01); A61K 9/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 9/0019 (2013.01); A61K 9/1272 (2013.01); A61K 39/12 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/585 (2013.01); C12N 2710/20022 (2013.01); C12N 2710/20034 (2013.01); C12N 2710/20071 (2013.01);
Abstract

Novel human papillomovirus immunogenic compositions and methods of use thereof are provided. The compositions comprise unique combinations of multi-epitope peptide sequences specifically selected and designed to be effectively processed and cross-presented to T-cells. The peptides utilized in the compositions display high levels of binding with HLA-supertypes. The immunogenic compositions are broadly applicable to large proportions of target populations. The compositions comprise adjuvants such as cationic lipids.


Find Patent Forward Citations

Loading…